Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
Single centre, open-label, random order, cross-over trial, recruited over a period of approximately 2 years. Sufficient participants enrolled to complete 16 adults. Withdrawn subjects may be replaced. This clinical trial will assess the effects of ultra-long acting bronchodilator therapy in smoking asthmatics taking inhaled corticosteroids. This will be via a pulmonary function test called impulse oscillometry.
Epistemonikos ID: e8eae2737b30e3e399d1189a7f7f027f6e7a1232
First added on: Dec 20, 2022